1
|
Tariq K and Ghias K: Colorectal cancer
carcinogenesis: A review of mechanisms. Cancer Biol Med.
13:120–135. 2016. View Article : Google Scholar : PubMed/NCBI
|
2
|
Mármol I, Sánchez-de-Diego C, Pradilla
Dieste A, Cerrada E and Rodriguez Yoldi MJ: Colorectal carcinoma: A
general overview and future perspectives in colorectal cancer. Int
J Mol Sci. 18(pii): E1972017. View Article : Google Scholar : PubMed/NCBI
|
3
|
Armstrong B and Doll R: Environmental
factors and cancer incidence and mortality in different countries,
with special reference to dietary practices. Int J Cancer.
15:617–631. 1975. View Article : Google Scholar : PubMed/NCBI
|
4
|
Doll R and Peto R: The causes of cancer:
Quantitative estimates of avoidable risks of cancer in the United
States today. J Natl Cancer Inst. 66:1191–1308. 1981. View Article : Google Scholar : PubMed/NCBI
|
5
|
Song M, Garrett WS and Chan AT: Nutrients,
foods, and colorectal cancer prevention. Gastroenterology.
148:1244–1260.e16. 2015. View Article : Google Scholar : PubMed/NCBI
|
6
|
Chan DS, Lau R, Aune D, Vieira R,
Greenwood DC, Kampman E and Norat T: Red and processed meat and
colorectal cancer incidence: Meta-analysis of prospective studies.
PLoS One. 6:e204562011. View Article : Google Scholar : PubMed/NCBI
|
7
|
Chao A, Thun MJ, Connell CJ, McCullough
ML, Jacobs EJ, Flanders WD, Rodriguez C, Sinha R and Calle EE: Meat
consumption and risk of colorectal cancer. JAMA. 293:172–182. 2005.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Holt PR, Atillasoy EO, Gilman J, Guss J,
Moss SF, Newmark H, Fan K, Yang K and Lipkin M: Modulation of
abnormal colonic epithelial cell proliferation and differentiation
by low-fat dairy foods: A randomized controlled trial. JAMA.
280:1074–1079. 1998. View Article : Google Scholar : PubMed/NCBI
|
9
|
Glinghammar B, Venturi M, Rowland IR and
Rafter JJ: Shift from a dairy product-rich to a dairy product-free
diet: Influence on cytotoxicity and genotoxicity of fecal
water-potential risk factors for colon cancer. Am J Clin Nutr.
66:1277–1282. 1997. View Article : Google Scholar : PubMed/NCBI
|
10
|
Norat T and Riboli E: Dairy products and
colorectal cancer. A review of possible mechanisms and
epidemiological evidence. Eur J Clin Nutr. 57:1–17. 2003.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Wollowski I, Ji ST, Bakalinsky AT,
Neudecker C and Pool-Zobel BL: Bacteria used for the production of
yogurt inactivate carcinogens and prevent DNA damage in the colon
of rats. J Nutr. 129:77–82. 1999. View Article : Google Scholar : PubMed/NCBI
|
12
|
Kesse E, Boutron-Ruault MC, Norat T,
Riboli E and Clavel-Chapelon F; E3N Group, : Dietary calcium,
phosphorus, vitamin D, dairy products and the risk of colorectal
adenoma and cancer among French women of the E3N-EPIC prospective
study. Int J Cancer. 117:137–144. 2005. View Article : Google Scholar : PubMed/NCBI
|
13
|
Cho E, Smith-Warner SA, Spiegelman D,
Beeson WL, van den Brandt PA, Colditz GA, Folsom AR, Fraser GE,
Freudenheim JL, Giovannucci E, et al: Dairy foods, calcium, and
colorectal cancer: A pooled analysis of 10 cohort studies. J Natl
Cancer Inst. 96:1015–1022. 2004. View Article : Google Scholar : PubMed/NCBI
|
14
|
Giovannucci E, Rimm EB, Stampfer MJ,
Colditz GA, Ascherio A and Willett WC: Intake of fat, meat, and
fiber in relation to risk of colon cancer in men. Cancer Res.
54:2390–2397. 1994.PubMed/NCBI
|
15
|
Park Y, Leitzmann MF, Subar AF, Hollenbeck
A and Schatzkin A: Dairy food, calcium, and risk of cancer in the
NIH-AARP diet and health study. Arch Intern Med. 169:391–401. 2009.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Lee SA, Shu XO, Yang G, Li H, Gao YT and
Zheng W: Animal origin foods and colorectal cancer risk: A report
from the Shanghai Women's health study. Nutr Cancer. 61:194–205.
2009. View Article : Google Scholar : PubMed/NCBI
|
17
|
Ball DW: The chemical composition of maple
syrup. J Chem Educ. 84:16472007. View Article : Google Scholar
|
18
|
Perkins TD and van den Berg AK: Maple
syrup-production, composition, chemistry, and sensory
characteristics. Adv Food Nutr Res. 56:101–143. 2009. View Article : Google Scholar : PubMed/NCBI
|
19
|
Arnason T, Hebda RJ and Johns T: Use of
plants for food and medicine by Native People's of eastern Canada.
Can J Bot. 59:2189–2325. 1981. View
Article : Google Scholar
|
20
|
Apostolidis E, Li L, Lee C and Seeram NP:
In vitro evaluation of phenolic-enriched maple syrup extracts for
inhibition of carbohydrate hydrolyzing enzymes relevant to type 2
diabetes management. J Funct Foods. 3:100–106. 2011. View Article : Google Scholar
|
21
|
Legault J, Girard-Lalancette K, Grenon C,
Dussault C and Pichette A: Antioxidant activity, inhibition of
nitric oxide overproduction, and in vitro antiproliferative effect
of maple sap and syrup from Acer saccharum. J Med Food. 13:460–468.
2010. View Article : Google Scholar : PubMed/NCBI
|
22
|
González-Sarrías A, Li L and Seeram NP:
Effects of maple (Acer) plant part extracts on proliferation,
apoptosis and cell cycle arrest of human tumorigenic and
non-tumorigenic colon cells. Phytother Res. 26:995–1002. 2012.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Theriault M, Caillet S, Kermasha S and
Lacroix M: Antioxidant, antiradical and antimutagenic activities of
phenolic compounds present in maple products. Food Chem.
98:490–501. 2006. View Article : Google Scholar
|
24
|
Hawco CL, Wang Y, Taylor M and Weaver DF:
A maple syrup extract prevents β-amyloid aggregation. Can J Neurol
Sci. 43:198–201. 2016. View Article : Google Scholar : PubMed/NCBI
|
25
|
Nagai N, Ito Y and Taga A: Comparison of
the enhancement of plasma glucose levels in type 2 diabetes otsuka
long-evans tokushima fatty rats by oral administration of sucrose
or maple syrup. J Oleo Sci. 62:737–743. 2013. View Article : Google Scholar : PubMed/NCBI
|
26
|
Nagai N, Yamamoto T, Tanabe W, Ito Y,
Kurabuchi S, Mitamura K and Taga A: Changes in plasma glucose in
otsuka long-evans tokushima fatty rats after oral administration of
maple syrup. J Oleo Sci. 64:331–335. 2015. View Article : Google Scholar : PubMed/NCBI
|
27
|
Kim YT and Leech RH: Effects of climatic
conditions on sap flow in sugar maple. Forest Chron. 61:303–307.
1985. View Article : Google Scholar
|
28
|
Marvin JW and Erickson RO: A statistical
evaluation of some of the factors responsible for the flow of sap
from the sugar maple. Plant Physiol. 31:57–61. 1956. View Article : Google Scholar : PubMed/NCBI
|
29
|
Houle D, Paquette A, Côté B, Logan T,
Power H, Charron I and Duchesne L: Impacts of climate change on the
timing of the production season of maple syrup in Eastern Canada.
PLoS One. 10:e01448442015. View Article : Google Scholar : PubMed/NCBI
|
30
|
Yamamoto T, Uemura K, Moriyama K, Mitamura
K and Taga A: Inhibitory effect of maple syrup on the cell growth
and invasion of human colorectal cancer cells. Oncol Rep.
33:1579–1584. 2015. View Article : Google Scholar : PubMed/NCBI
|
31
|
Yamamoto T, Sato K, Kubota Y, Mitamura K
and Taga A: Effect of dark-colored maple syrup on cell
proliferation of human gastrointestinal cancer cell. Biomed Rep.
7:6–10. 2017. View Article : Google Scholar : PubMed/NCBI
|
32
|
Maple products regulation. https://laws-lois.justice.gc.ca/eng/regulations/C.R.C.,_c._289/page-8.html#h-24
|
33
|
Bluemlein K and Ralser M: Monitoring
protein expression in whole-cell extracts by targeted label- and
standard-free LC-MS/MS. Nat Protoc. 6:859–869. 2011. View Article : Google Scholar : PubMed/NCBI
|
34
|
Old WM, Meyer-Arendt K, Aveline-Wolf L,
Pierce KG, Mendoza A, Sevinsky JR, Resing KA and Ahn NG: Comparison
of label-free methods for quantifying human proteins by shotgun
proteomics. Mol Cell Proteomics. 4:1487–1502. 2005. View Article : Google Scholar : PubMed/NCBI
|
35
|
Zybailov B, Coleman MK, Florens L and
Washburn MP: Correlation of relative abundance ratios derived from
peptide ion chromatograms and spectrum counting for quantitative
proteomic analysis using stable isotope labeling. Anal Chem.
77:6218–6224. 2005. View Article : Google Scholar : PubMed/NCBI
|
36
|
Dennis G Jr, Sherman BT, Hosack DA, Yang
J, Gao W, Lane HC and Lempicki RA: DAVID: Database for annotation,
visualization, and integrated discovery. Genome Biol. 4:P32003.
View Article : Google Scholar : PubMed/NCBI
|
37
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
38
|
Huang da W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
39
|
Parikh P, Bai H, Swartz MF, Alfieris GM
and Dean DA: Identification of differentially regulated genes in
human patent ductus arteriosus. Exp Biol Med (Maywood).
241:2112–2118. 2016. View Article : Google Scholar : PubMed/NCBI
|
40
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
41
|
Carbotti G, Nikpoor AR, Vacca P, Gangemi
R, Giordano C, Campelli F, Ferrini S and Fabbi M: IL-27 mediates
HLA class I up-regulation, which can be inhibited by the IL-6
pathway, in HLA-deficient small cell lung cancer cells. J Exp Clin
Cancer Res. 36:1402017. View Article : Google Scholar : PubMed/NCBI
|
42
|
Adnan M, Morton G and Hadi S: Analysis of
rpoS and bolA gene expression under various stress-induced
environments in planktonic and biofilm phase using 2(−ΔΔCT) method.
Mol Cell Biochem. 357:275–282. 2011. View Article : Google Scholar : PubMed/NCBI
|
43
|
Soejima M and Koda Y: TaqMan-based
real-time polymerase chain reaction for detection of FUT2 copy
number variations: Identification of novel Alu-mediated deletion.
Transfusion. 51:762–769. 2011. View Article : Google Scholar : PubMed/NCBI
|
44
|
Kelman Z: PCNA: Structure, functions and
interactions. Oncogene. 14:629–640. 1997. View Article : Google Scholar : PubMed/NCBI
|
45
|
Majka J and Burgers PM: The PCNA-RFC
families of DNA clamps and clamp loaders. Prog Nucleic Acid Res Mol
Biol. 78:227–260. 2004. View Article : Google Scholar : PubMed/NCBI
|
46
|
Moldovan GL, Pfander B and Jentsch S:
PCNA, the maestro of the replication fork. Cell. 129:665–679. 2007.
View Article : Google Scholar : PubMed/NCBI
|
47
|
Bártová E, Suchánková J, Legartová S,
Malyšková B, Hornáček M, Skalníková M, Mašata M, Raška I and
Kozubek S: PCNA is recruited to irradiated chromatin in late
S-phase and is most pronounced in G2 phase of the cell cycle.
Protoplasma. 254:2035–2043. 2017. View Article : Google Scholar : PubMed/NCBI
|
48
|
Budhavarapu VN, Chavez M and Tyler JK: How
is epigenetic information maintained through DNA replication?
Epigenetics Chromatin. 6:322013. View Article : Google Scholar : PubMed/NCBI
|
49
|
Celis JE and Celis A: Cell cycle-dependent
variations in the distribution of the nuclear protein cyclin
proliferating cell nuclear antigen in cultured cells: Subdivision
of S phase. Proc Natl Acad Sci USA. 82:3262–3266. 1985. View Article : Google Scholar : PubMed/NCBI
|
50
|
Schönenberger F, Deutzmann A, Ferrando-May
E and Merhof D: Discrimination of cell cycle phases in
PCNA-immunolabeled cells. BMC Bioinformatics. 16:1802015.
View Article : Google Scholar : PubMed/NCBI
|
51
|
Liu B, Zhou Z, Zhou W, Liu J, Zhang Q, Xia
J, Liu J, Chen N, Li M and Zhu R: Resveratrol inhibits
proliferation in human colorectal carcinoma cells by inducing
G1/S-phase cell cycle arrest and apoptosis through
caspase/cyclin-CDK pathways. Mol Med Rep. 10:1697–1702. 2014.
View Article : Google Scholar : PubMed/NCBI
|
52
|
Qin JL, Shen WY, Chen ZF, Zhao LF, Qin QP,
Yu YC and Liang H: Oxoaporphine metal complexes (CoII,
NiII, ZnII) with high antitumor activity by
inducing mitochondria-mediated apoptosis and S-phase arrest in
HepG2. Sci Rep. 7:460562017. View Article : Google Scholar : PubMed/NCBI
|
53
|
Zhao H, Hu X, Cao K, Zhang Y, Zhao K, Tang
C and Feng B: Synthesis and SAR of
4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivatives as potent and
selective CDK4/6 inhibitors. Eur J Med Chem. 157:935–945. 2018.
View Article : Google Scholar : PubMed/NCBI
|
54
|
Goel S, DeCristo MJ, Watt AC, BrinJones H,
Sceneay J, Li BB, Khan N, Ubellacker JM, Xie S, Metzger-Filho O, et
al: CDK4/6 inhibition triggers anti-tumour immunity. Nature.
548:471–475. 2017. View Article : Google Scholar : PubMed/NCBI
|
55
|
Finn RS, Crown JP, Lang I, Boer K,
Bondarenko IM, Kulyk SO, Ettl J, Patel R, Pinter T, Schmidt M, et
al: The cyclin-dependent kinase 4/6 inhibitor palbociclib in
combination with letrozole versus letrozole alone as first-line
treatment of oestrogen receptor-positive, HER2-negative, advanced
breast cancer (PALOMA-1/TRIO-18): A randomised phase 2 study.
Lancet Oncol. 16:25–35. 2015. View Article : Google Scholar : PubMed/NCBI
|
56
|
Cristofanilli M, Turner NC, Bondarenko I,
Ro J, Im SA, Masuda N, Colleoni M, DeMichele A, Loi S, Verma S, et
al: Fulvestrant plus palbociclib versus fulvestrant plus placebo
for treatment of hormone-receptor-positive, HER2-negative
metastatic breast cancer that progressed on previous endocrine
therapy (PALOMA-3): Final analysis of the multicentre,
double-blind, phase 3 randomised controlled trial. Lancet Oncol.
17:425–439. 2016. View Article : Google Scholar : PubMed/NCBI
|
57
|
Krimpenfort P, Ijpenberg A, Song JY, van
der Valk M, Nawijn M, Zevenhoven J and Berns A: p15Ink4b is a
critical tumour suppressor in the absence of p16Ink4a. Nature.
448:943–946. 2007. View Article : Google Scholar : PubMed/NCBI
|
58
|
Nanda V, Downing KP, Ye J, Xiao S, Kojima
Y, Spin JM, DiRenzo D, Nead KT, Connolly AJ, Dandona S, et al:
CDKN2B regulates TGFβ signaling and smooth muscle cell investment
of hypoxic neovessels. Circ Res. 118:230–240. 2016. View Article : Google Scholar : PubMed/NCBI
|
59
|
González-Sarrías A, Ma H, Edmonds ME and
Seeram NP: Maple polyphenols, ginnalins A-C, induce S- and
G2/M-cell cycle arrest in colon and breast cancer cells mediated by
decreasing cyclins A and D1 levels. Food Chem. 136:636–642. 2013.
View Article : Google Scholar : PubMed/NCBI
|